REHABILITATION OF FUNCTIONALLY CLASS-III CARDIAC PATIENT

被引：0

|

作者：

MILLER, H ^{[1
]}

RIBISL, P ^{[1
]}

BOONE, T ^{[1
]}

ADAMS, G ^{[1
]}

KEITH, T ^{[1
]}

JACKSON, C ^{[1
]}

机构：

[1] WAKE FOREST UNIV,WINSTON SALEM,NC 27109

来源：

CIRCULATION | 1978年 / 58卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：205 / 205

页数：1

相关论文

共 50 条

[41] STUDIES ON CLASS-III GENE-TRANSCRIPTION
SHASTRY, BS
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1993, 121 (02) : 135 - 141
[42] DOFETILIDE, A NOVEL CLASS-III ANTIARRHYTHMIC AGENT
RASMUSSEN, HS
ALLEN, MJ
BLACKBURN, KJ
BUTROUS, GS
DALRYMPLE, HW
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 : S96 - S105
[43] THE DILEMMA OF CLASS-III TREATMENT - EARLY OR LATE
CAMPBELL, PM
ANGLE ORTHODONTIST, 1983, 53 (03) : 175 - 191
[44] DEVELOPMENTAL CHARACTERIZATION OF SKELETAL CLASS-III MALOCCLUSION
SATO, S
ANGLE ORTHODONTIST, 1994, 64 (02) : 105 - 111
[45] A MODE OF ACTION OF CLASS-III ANTIARRHYTHMIC DRUGS
PLATOU, ES
REFSUM, H
EUROPEAN HEART JOURNAL, 1985, 6 : 184 - 184
[46] PROARRHYTHMIC EFFECTS OF CLASS-III ANTIARRHYTHMIC AGENTS
REES, S
CARDIOVASCULAR RESEARCH, 1993, 27 (12) : 2285 - 2286
[47] THE PREMARKET REVIEW PROCESS FOR CLASS-III DEVICES
VONOEHSEN, WHE
BIO-TECHNOLOGY, 1989, 7 (09): : 897 - &
[48] IS IT PRACTICAL TO DEVELOP A CLASS-III ANTIARRHYTHMIC AGENT
AGERSBORG, HPK
LATTS, J
RISK/BENEFIT ANALYSIS FOR THE USE AND APPROVAL OF THROMBOLYTIC, ANTIARRHYTHMIC, AND HYPOLIPIDEMIC AGENTS, 1989, : 157 - 166
[49] COMPONENTS OF CLASS-III MALOCCLUSION IN JUVENILES AND ADOLESCENTS
GUYER, EC
ELLIS, EE
MCNAMARA, JA
BEHRENTS, RG
ANGLE ORTHODONTIST, 1986, 56 (01) : 7 - 30
[50] CLASS-III ANTIARRHYTHMIC ACTION - THE WAY FORWARD
CAMPBELL, TJ
MEDICAL JOURNAL OF AUSTRALIA, 1993, 158 (11) : 732 - 733

← 1 2 3 4 5 →